ImpediMed Limited (ASX:IPD)

ImpediMed Revenue

ImpediMed had revenue of 6.01M AUD in the half year ending December 31, 2024, with 6.24% growth. This brings the company's revenue in the last twelve months to 11.54M, up 10.22% year-over-year. In the fiscal year ending June 30, 2024, ImpediMed had annual revenue of 10.32M, down -9.04%.

• Revenue (ttm): 11.54M
• Revenue Growth: +10.22%
• P/S Ratio: 5.97
• Revenue / Employee: 139.07K
• Employees: 83
• Market Cap: 68.87M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	10.32M	-1.03M	-9.04%
Jun 30, 2023	11.34M	778.00K	7.36%
Jun 30, 2022	10.57M	2.16M	25.65%
Jun 30, 2021	8.41M	2.67M	46.47%
Jun 30, 2020	5.74M	1.59M	38.14%